Learn More
Discover how biome therapeutics and endolysin science can help patients with inflammatory skin conditions. Learn how to put GladskinMD to work in your practice.
-
White Papers
- Staphylococcus aureus – from skin colonization to severe infection
- Targeted Endolysin Therapy for the Treatment of Inflammatory Acne
- Treatment of Eczema with Targeted Endolysin Therapy
- Treatment of Folliculitis Furunculosis with Targeted Endolysins
- Treatment of Rosacea with Targeted Endolysin Therapy
- Understanding Colonization Infection Continuum with Targeted Endolysins
-
Clinical Validations
- Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis
- Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with the Topical Endolysin Staphefekt SA.100: A Report of 3 Cases
- Bacteriophage endolysins as novel antimicrobials
- Bacteriophage endolysins - extending their application to tissues and the bloodstream
- Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection
- Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus Infection
- The Advantages and Challenges of Using Endolysins in a Clinical Setting
- Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies
